體外膜氧合治療H5N6重癥禽流感患者一例_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

雷證 ¹ , 羅吉 ¹ , 陳冬菊 ¹ , 陳琴 ¹ , 楊浩 ² , 王波 ² ,  張遠軍 ¹

1. ;
2. ;

Corresponding?author：

張遠軍, Email: 57207057@qq.com

Keywords：

DOI：

10.7507/1671-6205.202403041

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 雷證, 羅吉, 陳冬菊, 陳琴, 楊浩, 王波, 張遠軍. 體外膜氧合治療H5N6重癥禽流感患者一例. Chinese Journal of Respiratory and Critical Care Medicine, 2025, 24(1): 51-53. doi: 10.7507/1671-6205.202403041 Copy

1.	Wang L, Wang D, Zhang T, et al. Extracorporeal membrane oxygenation for COVID-19 and influenza associated acute respiratory distress syndrome: a systematic review. Expert Rev Respir Med, 2023, 17(10): 951-959.
2.	郭振東. H5N6亞型禽流感病毒跨種感染哺乳動物的致病與傳播風險研究. 軍事科學院, 2019.
3.	劉麗娜, 趙宗正, 郭振東, 等. 人感染H5N6亞型禽流感病毒研究進展. 軍事醫學, 2017, 41(1): 69-72.
4.	Surveillance Division of the Communicable Disease Branch of the Centre for Health Protection (2023). Avian Influenza Report, volume 19 (China: Department of Health, Government of the Hong Kong Special Administrative Region), number 30. https://www.chp.gov.hk/files/pdf/ 2023_avian_influenza_report_vol19_wk30.pdf.
5.	Pan M, Gao R, Lv Q, et al. Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: Virological and clinical findings. J Infect, 2016, 72(1): 52-59.
6.	Steven JL, Vincent AP, Warwick B, et al. Extracorporeal membrane oxygenation. Med J Aust, 2009, 191(3): 178-182.
7.	張偉明, 方樹珊, 唐松元, 等. 奧司他韋對高致病性H5N6亞型禽流感病毒的抑制效果評價. 現代畜牧獸醫, 2019(8): 12-16.
8.	Guan W, Qu R, Shen L, et al. Baloxavir marboxil use for critical human infection of avian influenza A H5N6 virus. Med, 2024, 5(1): 32-41.
9.	Wu W, Shi Y, Gao H, et al. Immune derangement occurs in patients with H7N9 avian influenza. Crit Care, 2014, 18(2): R43.

1. Wang L, Wang D, Zhang T, et al. Extracorporeal membrane oxygenation for COVID-19 and influenza associated acute respiratory distress syndrome: a systematic review. Expert Rev Respir Med, 2023, 17(10): 951-959.
2. 郭振東. H5N6亞型禽流感病毒跨種感染哺乳動物的致病與傳播風險研究. 軍事科學院, 2019.
3. 劉麗娜, 趙宗正, 郭振東, 等. 人感染H5N6亞型禽流感病毒研究進展. 軍事醫學, 2017, 41(1): 69-72.
4. Surveillance Division of the Communicable Disease Branch of the Centre for Health Protection (2023). Avian Influenza Report, volume 19 (China: Department of Health, Government of the Hong Kong Special Administrative Region), number 30. https://www.chp.gov.hk/files/pdf/ 2023_avian_influenza_report_vol19_wk30.pdf.
5. Pan M, Gao R, Lv Q, et al. Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: Virological and clinical findings. J Infect, 2016, 72(1): 52-59.
6. Steven JL, Vincent AP, Warwick B, et al. Extracorporeal membrane oxygenation. Med J Aust, 2009, 191(3): 178-182.
7. 張偉明, 方樹珊, 唐松元, 等. 奧司他韋對高致病性H5N6亞型禽流感病毒的抑制效果評價. 現代畜牧獸醫, 2019(8): 12-16.
8. Guan W, Qu R, Shen L, et al. Baloxavir marboxil use for critical human infection of avian influenza A H5N6 virus. Med, 2024, 5(1): 32-41.
9. Wu W, Shi Y, Gao H, et al. Immune derangement occurs in patients with H7N9 avian influenza. Crit Care, 2014, 18(2): R43.

Chinese Journal of Respiratory and Critical Care Medicine

體外膜氧合治療H5N6重癥禽流感患者一例

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content